Amneal Pharmaceuticals, Inc. AMRX AvKARE — Other Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s avkare — other operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s avkare — other operating income?
- Amneal Pharmaceuticals, Inc. (AMRX) reported avkare — other operating income of $0 in Q1 2026.
- What does avkare — other operating income mean?
- Captures miscellaneous operating income or expenses that do not fall under standard categories like cost of goods sold or SG&A. It reflects secondary operational activities that impact the segment's overall profitability.